Delivery Order SPE2DB20D2104-SPE2DB22FS63Q
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Dupixent 200 mg/1.14 ml syringes. The $52,992.43 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of February 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, with a ceiling value of $19,647.96 and a performance period through November 7, 2023. The contract is a firm-fixed-price type, without any set-aside designation. Amerisourcebergen, a major...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,568.72 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, with a completion date of June 1, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,389.04 firm fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml syringe and has an ultimate completion date of January 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Dupixent 300 mg/2 ml syringe (2 ml) to the Defense Logistics Agency (DLA) Troop Support Medical. The $25,934.80 firm-fixed-price delivery order has an ultimate completion date of October 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Dupixent 300 mg/2 ml syringes. The $6,422.04 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of February 3, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The $20,066.18 firm-fixed-price delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml syringe. The contract has an ultimate completion date of May 1, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,987.20 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes to support military and government healthcare requirements. The contract has a period of performance through September 21, 2023 and was not set aside for any specific business category. Amerisourcebergen, as a major pharmaceutical distributor, holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $9,177.99 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Dupixent 200 mg/1.14 ml syringes, a specialty pharmaceutical product. This award is not designated as a set-aside contract. The IDC with the DLA Troop Support Medical, valued at up to $999,999,999.00, serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,871.24 firm fixed-price delivery order is for Dupixent 300 mg/2 ml syringes. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS63QDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $26,954.16 firm fixed-price contract is for the supply of Dupixent 300 mg/2 ml syringes, with a performance period ending on May 6, 2022. Amerisourcebergen, a major pharmaceutical distributor, has a significant $999,999,999 IDC with the DLA Troop Support Medical that runs through November 2026. This IDC serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.0k | 5/5/22 |